EUVIMEDEUVIMED entdecken
Crossref

Baseline platelet serotonin in a multi-site treatment study of depression in veterans administration patients: Distribution and effects of demographic variables and serotonin reuptake inhibitors

George M Anderson, Christine M Ramsey, Kevin G Lynch, Joel Gelernter, David W Oslin

Journal of Affective Disorders · 2023

DOI: 10.1016/j.jad.2023.02.017 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Affective Disorders, 2023. Verfasst von George M Anderson und 4 weiteren Autor:innen. Beteiligte Einrichtung: Child Study Center, Yale University School of Medicine, 230 S. Frontage Rd., New Haven, CT 06525, USA; Department of Laboratory Medicine, Yale Univer…. Hauptthemen laut MEDLINE: Selective Serotonin Reuptake Inhibitors, Serotonin and Noradrenaline Reuptake Inhibitors. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 83 Literaturangaben. Gefördert von: HSRD VA, Janssen Pharmaceuticals, U.S. Department of Veterans Affairs.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The objectives of the study were: (1) to examine the overall distribution of baseline platelet serotonin (5-hydroxytryptamine, 5-HT) values in patients seeking treatment for depression and to define subgroups based on the apparent presence or absence of drug exposure; (2) to assess the bioeffect of 5-HT reuptake inhibitors (SRIs) at the platelet 5-HT transporter; and (3) to examine the relationships of demographic variables including population (ancestry), sex, age, and season of sampling to platelet 5-HT concentration. METHODS: Platelet 5-HT levels were measured in a cross-sectional study of 1433 Veterans Administration (VA) patients participating in a pragmatic multi-site pharmacogenomic treatment study of depression. Patients were characterized medically and demographically using VA health records and self-report. RESULTS: A clearly bimodal distribution was observed for platelet 5-HT levels with the lower mode associated with patients exposed to SRIs at baseline. Median transporter blockade bioeffects were similar across the various selective 5-HT reuptake inhibitors (SSRIs) and 5-HT/norepinephrine reuptake inhibitors (SNRIs). In a subset of patients apparently not exposed to an SRI, significant effects of population and sex were observed with group mean platelet 5-HT levels being 25 % greater (p < 0.001) in African-American (AA) individuals compared to European-Americans (EAs). The female group mean was 14 % (p < 0.001) greater than male group mean. An effect of age was observed (r = -0.11, p < 0.001) and no effect of season or month of sampling was seen. CONCLUSIONS: Further research is warranted to understand the bases and clinical implications of the population and sex differences. The apparent similarity in bioeffect at the 5-HT transporter across SSRIs and when comparing SSRIs and SNRIs informs discussions about initiating, dose adjustment and switching of 5-HT reuptake inhibitors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Selective Serotonin Reuptake InhibitorsSerotonin and Noradrenaline Reuptake InhibitorsUnited StatesHumansFemaleMaleSerotoninDepressionCross-Sectional StudiesUnited States Department of Veterans AffairsMembrane Transport ProteinsDemography

Stichwörter der Autor:innen

DepressionPlateletSelective serotonin reuptake inhibitor (SSRI)SerotoninSerotonin reuptake inhibitor (SRI)Veterans

Substanzen

Selective Serotonin Reuptake InhibitorsSerotoninSerotonin and Noradrenaline Reuptake InhibitorsMembrane Transport Proteins

Autor:innen und Institutionen

  • Child Study Center, Yale University School of Medicine, 230 S. Frontage Rd., New Haven, CT 06525, USA; Department of Laboratory Medicine, Yale University School of Medicine, 230 S. Frontage Rd., New Haven, CT 06525, USA…
  • Veterans Integrated Service Network 4, Mental Illness Research, Education, and Clinical Center (MIRECC), Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA, USA; Yale Center for Medical Informatics, Yale U…
  • Veterans Integrated Service Network 4, Mental Illness Research, Education, and Clinical Center (MIRECC), Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA, USA; Perelman School of Medicine, University of…
  • Department of Psychiatry, Yale University School of Medicine, West Haven, CT, USA; Department of Psychiatry, Veterans Affairs Connecticut Healthcare Center, West Haven, CT, USA.

Förderung

  • HSRD VA
  • Janssen Pharmaceuticals
  • U.S. Department of Veterans Affairs
  • Myriad Genetics
  • Office of Research and Development
  • U.S. Department of Defense
  • Health Services Research and Development

Zitieren

APA

Anderson, G. M., Ramsey, C. M., Lynch, K. G., Gelernter, J., & Oslin, D. W. (2023). Baseline platelet serotonin in a multi-site treatment study of depression in veterans administration patients: Distribution and effects of demographic variables and serotonin reuptake inhibitors. Journal of Affective Disorders. https://doi.org/10.1016/j.jad.2023.02.017

Vancouver

Anderson GM, Ramsey CM, Lynch KG, Gelernter J, Oslin DW. Baseline platelet serotonin in a multi-site treatment study of depression in veterans administration patients: Distribution and effects of demographic variables and serotonin reuptake inhibitors. Journal of Affective Disorders. 2023. doi:10.1016/j.jad.2023.02.017

BibTeX
@article{Anderson2023,
  author = {Anderson, George M and Ramsey, Christine M and Lynch, Kevin G and Gelernter, Joel and Oslin, David W},
  title = {Baseline platelet serotonin in a multi-site treatment study of depression in veterans administration patients: Distribution and effects of demographic variables and serotonin reuptake inhibitors},
  journal = {Journal of Affective Disorders},
  year = {2023},
  doi = {10.1016/j.jad.2023.02.017}
}
Kostenlos starten →